Amneal Pharmaceuticals, Inc. AMRX Specialty — Charges related to legal matters, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GainLossRelatedToLitigationSettlement.
The official record: Amneal Pharmaceuticals, Inc.’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s specialty — charges related to legal matters, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s specialty — charges related to legal matters, net?
- Amneal Pharmaceuticals, Inc. (AMRX) reported specialty — charges related to legal matters, net of $0 in Q4 2025.
- What does specialty — charges related to legal matters, net mean?
- Represents the net financial impact of legal settlements, litigation costs, and related legal provisions incurred by the Specialty segment. This metric highlights potential operational risks and the impact of legal contingencies on the segment's profitability.